CNRC — Installation de recherche sur les poissons zèbres ### 📋 Eligible Entities - Private sector companies developing natural health products and human health therapeutics - Biopharmaceutical firms requiring toxicological and pharmacological testing - Contract research organizations (CROs) conducting product safety evaluations - Health product manufacturers seeking regulatory compliance testing - Small to medium-sized enterprises (SMEs) in the natural health and pharmaceutical sectors - Academic institutions and research centers conducting commercial testing services ### 💰 Funding Details - Grant Structure: Fee-for-service model (not a traditional grant disbursement) - Funding Mechanism: Access to paid testing services at CNRC's zebra fish research facility - Cost Model: Users pay for testing services on a per-project basis - Repayability: Not applicable (service-based; no loan component) - Matching Requirements: None specified (direct payment for services rendered) - Budget Range: Varies by test scope and complexity; individual project quotes required ### 🛠️ Approved Expenses - Toxicological testing of natural health products - Pharmacological property evaluation for human health therapeutics - Safety assessment of medicinal compounds - Regulatory compliance testing for product approval pathways - In vivo testing protocols using zebra fish models - Data generation for regulatory submissions (Health Canada, FDA, etc.) - Specialized analytical services related to product efficacy and safety ### ⚠️ Conditions & Milestones - Facility Access: Projects must be conducted within CNRC's zebra fish research installation - Testing Standards: All assessments must comply with CNRC scientific protocols and international testing standards - Regulatory Alignment: Results must meet requirements for human health product licensing (Health Canada, etc.) - Project Scoping: Detailed project proposals required before service delivery - Payment Terms: Fees due according to CNRC's standard payment schedule (typically upon completion of testing phases) - Intellectual Property: Clear IP agreements required; CNRC retains ownership of facility methods